The U.S. androgenetic alopecia market was valued at USD 979.1 million in 2024 and is expected to grow at a CAGR of 6.6% from 2025 to 2030. The increasing incidence of Androgenic Alopecia (AGA) is driving market growth. Androgenetic alopecia, the most common form of hair loss, affects a s... Read More »
June 2025The global infant nutrition market size was valued at USD 392.1 million in 2024 and is projected to reach USD 611.1 million by 2030, growing at a CAGR of 7.7% from 2025 to 2030. The market growth is driven by factors such as increasing awareness and acceptance of infant nutrition product... Read More »
June 2025The global herbal supplements market size was estimated at USD 42.33 billion in 2024 and is anticipated to reach USD 90.24 billion in 2033, growing at a CAGR of 8.89% from 2025 to 2033. This growth is driven by rising consumer health consciousness, a growing preference for natural and pl... Read More »
June 2025The global rozanolixizumab (Rystiggo) market size was estimated at USD 218.61 million in 2024 and is projected to reach USD 1,700.40 million by 2033, growing at a CAGR of 15.22% from 2025 to 2033. The increasing prevalence of chronic plaque psoriasis and psoriatic arthritis drives greate... Read More »
June 2025The U.S. keytruda market size was estimated at USD 17.87 billion in 2024 and is projected to decline at a CAGR of -3.12% from 2025 to 2033. The market faces challenges from the impending patent expiration in 2028, introducing biosimilar competition. Although the decline is expected, mark... Read More »
June 2025The U.S. anti-aging supplements market was valued at USD 1.39 billion in 2024 and is expected to grow at a CAGR of 7.2% from 2025 to 2030. Growth is driven by increasing health consciousness, rising life expectancy, and a proactive approach to age-related health management among U.S. con... Read More »
June 2025The U.S. Rozanolixizumab (Rystiggo) market size was estimated at USD 199.13 million in 2024 and is expected to grow at a CAGR of 7.30% from 2025 to 2033. The U.S. Rozanolixizumab (Rystiggo) market focuses on treating generalized myasthenia gravis (gMG) in adults with anti-AChR or anti-Mu... Read More »
June 2025The global liver disease therapeutics market size was estimated at USD 20.31 billion in 2024 and is projected to reach USD 40.29 billion by 2033, growing at a CAGR of 7.9% from 2025 to 2033. Rising cases of NAFLD, hepatitis, and alcohol-related liver conditions, advancements in drug... Read More »
June 2025The Germany pharmaceutical market size was estimated at USD 95.11 billion in 2024 and is expected to grow at a CAGR of 5.31% from 2025 to 2033. The growth is driven by advances in digital health technologies supporting drug development and personalized medicine, such as AI and genome seq... Read More »
June 2025The global vaccine market size was estimated at USD 67.37 billion in 2024 and is projected to reach USD 115.77 billion by 2033, growing at a CAGR of 5.98% from 2025 to 2033. The market has been expanding globally, with an increase in vaccines targeting diseases that predominantly affect ... Read More »
June 2025The U.S. ultomiris drug market size was estimated at USD 1.46 billion in 2024 and is projected to reach USD 8.14 billion by 2033, growing at a CAGR of 19.93% from 2025 to 2033. Ultomiris continues to gain traction due to its extended dosing interval, which improves patient compliance and... Read More »
June 2025The global onychomycosis market was estimated at USD 3.81 billion in 2024 and is projected to reach USD 5.74 billion by 2033, growing at a CAGR of 4.7% from 2025 to 2033. The market is driven by the rising prevalence of fungal nail infections, increasing incidence of chronic conditions s... Read More »
June 2025The global peanut allergy treatment market size was estimated at USD 536.8 million in 2024 and is projected to reach USD 1,461.5 million by 2033, growing at a CAGR of 11.43% from 2025 to 2033. This market is witnessing robust expansion, fueled by rising peanut allergy prevalence and inno... Read More »
June 2025The UK Alzheimer’s therapeutics market size was estimated at USD 263.66 million in 2024 and is projected to reach USD 498.80 million by 2033, growing at a CAGR of 7.84% from 2025 to 2033. The increasing prevalence of Alzheimer’s disease in the UK is driving demand for effecti... Read More »
June 2025The U.S. enteral feeding formulas market size was estimated at USD 2.06 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2030. The increasing prevalence of chronic diseases, including cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obst... Read More »
June 2025The global Vyvgart (Efgartigimod) market size was estimated at USD 2.19 billion in 2024 and is projected to reach USD 5.50 billion by 2030, growing at a CAGR of 13.6% from 2025 to 2030. The market is experiencing significant growth, driven by several key factors. The increasing prevalenc... Read More »
June 2025The U.S. Zilbrysq (Zilucoplan) market size was estimated at USD 60.61 million in 2024 and is projected to grow at a CAGR of 21.64% from 2025 to 2030. The U.S. Zilbrysq (Zilucoplan) industry is witnessing robust growth following its FDA approval in October 2023 for the treatment of anti-A... Read More »
June 2025The global zilbrysq (zilucoplan) market size was estimated at USD 77.92 million in 2024 and is projected to reach USD 679.58 million by 2030, growing at a CAGR of 28.39% from 2025 to 2030. The market is experiencing significant growth, driven by its regulatory approvals in key markets su... Read More »
June 2025The global alopecia market size was estimated at USD 9.48 billion in 2024 and is projected to reach USD 16.02 billion by 2030, growing at a CAGR of 8.7% from 2025 to 2030. One of the major driving factors for the market is the increasing awareness regarding alopecia treatment options, as... Read More »
June 2025The global hemophilia market size was estimated at USD 14.11 billion in 2024 and is projected to reach USD 21.07 billion by 2030, growing at a CAGR of 6.91% from 2025 to 2030. The major factor driving the market is gene therapy approval, and multiple other candidates in various pipeline ... Read More »
June 2025